www.c-raytherapeutics.com

The startup develops radiopharmaceuticals that utilize radionuclide labeling for targeted tumor diagnosis and treatment. Their products provide precise therapeutic options for patients with cancer, enhancing treatment efficacy while minimizing side effects.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup develops radiopharmaceuticals that utilize radionuclide labeling for targeted tumor diagnosis and treatment. Their products provide precise therapeutic options for patients with cancer, enhancing treatment efficacy while minimizing side effects.